IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Cash Flow Statement
Cash Flow Statement
IOL Chemicals and Pharmaceuticals Ltd
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
5 332
|
5 926
|
5 714
|
3 911
|
2 249
|
1 621
|
1 887
|
2 323
|
1 817
|
1 348
|
1 380
|
1 585
|
|
| Depreciation & Amortization |
357
|
373
|
389
|
411
|
433
|
444
|
462
|
540
|
629
|
675
|
720
|
770
|
|
| Other Non-Cash Items |
159
|
(4)
|
(118)
|
(128)
|
(101)
|
(76)
|
(18)
|
6
|
(28)
|
5
|
79
|
64
|
|
| Cash Taxes Paid |
1 172
|
1 350
|
1 423
|
1 029
|
626
|
490
|
471
|
587
|
420
|
272
|
183
|
180
|
|
| Cash Interest Paid |
217
|
97
|
57
|
63
|
81
|
114
|
164
|
179
|
161
|
140
|
148
|
162
|
|
| Change in Working Capital |
(1 138)
|
(2 517)
|
(2 188)
|
(1 965)
|
(1 650)
|
(1 166)
|
(1 108)
|
(287)
|
483
|
(755)
|
(392)
|
(491)
|
|
| Cash from Operating Activities |
4 711
N/A
|
3 779
-20%
|
3 798
+0%
|
2 228
-41%
|
931
-58%
|
824
-11%
|
1 223
+48%
|
2 582
+111%
|
2 901
+12%
|
1 272
-56%
|
1 786
+40%
|
1 928
+8%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(803)
|
(877)
|
(1 082)
|
(1 525)
|
(1 533)
|
(1 361)
|
(2 118)
|
(2 520)
|
(2 742)
|
(2 860)
|
(2 136)
|
(1 525)
|
|
| Other Items |
(1 042)
|
(2 534)
|
(2 090)
|
(398)
|
331
|
397
|
918
|
548
|
829
|
1 479
|
594
|
(223)
|
|
| Cash from Investing Activities |
(1 845)
N/A
|
(3 412)
-85%
|
(3 173)
+7%
|
(1 923)
+39%
|
(1 202)
+38%
|
(965)
+20%
|
(1 200)
-24%
|
(1 972)
-64%
|
(1 913)
+3%
|
(1 381)
+28%
|
(1 542)
-12%
|
(1 748)
-13%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
280
|
280
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(2 296)
|
(879)
|
(571)
|
171
|
417
|
466
|
358
|
(289)
|
(471)
|
694
|
843
|
306
|
|
| Cash Paid for Dividends |
(206)
|
0
|
(235)
|
(352)
|
(352)
|
0
|
(235)
|
0
|
(294)
|
0
|
(235)
|
0
|
|
| Other |
(217)
|
(97)
|
(57)
|
(63)
|
(81)
|
(114)
|
(164)
|
(179)
|
(161)
|
(140)
|
(148)
|
(162)
|
|
| Cash from Financing Activities |
(2 719)
N/A
|
(901)
+67%
|
(583)
+35%
|
(245)
+58%
|
(16)
+93%
|
117
N/A
|
(41)
N/A
|
(704)
-1 612%
|
(925)
-31%
|
260
N/A
|
460
+77%
|
(91)
N/A
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
147
N/A
|
(534)
N/A
|
43
N/A
|
60
+42%
|
(288)
N/A
|
(24)
+92%
|
(18)
+22%
|
(94)
-410%
|
63
N/A
|
152
+140%
|
705
+365%
|
89
-87%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
3 908
N/A
|
2 902
-26%
|
2 716
-6%
|
703
-74%
|
(602)
N/A
|
(538)
+11%
|
(896)
-67%
|
62
N/A
|
159
+157%
|
(1 588)
N/A
|
(349)
+78%
|
403
N/A
|
|